Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/1209830.pdf
Reference49 articles.
1. Adams JM, Cory S . (1998). The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322–1326.
2. An J, Chen Y, Huang Z . (2004). Critical upstream signals of cytochrome c release induced by a novel Bcl-2 inhibitor. J Biol Chem 279: 19133–19140.
3. Autorino R, Di Lorenzo G, Damiano R, De Placido S, D’Armiento M . (2003). Role of chemotherapy in hormone-refractory prostate cancer. Old issues, recent advances and new perspectives. Urol Int 70: 1–14.
4. Bauer JJ, Sesterhenn IA, Mostofi FK, McLeod DG, Srivastava S, Moul JW . (1996). Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer. J Urol 156: 1511–1516.
5. Belka C, Jendrossek V, Pruschy M, Vink S, Verheij M, Budach W . (2004). Apoptosis-modulating agents in combination with radiotherapy – current status and outlook. Int J Radiat Oncol Biol Phys 58: 542–554.
Cited by 88 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A review on structure-function mechanism and signaling pathway of serine/threonine protein PIM kinases as a therapeutic target;International Journal of Biological Macromolecules;2024-06
2. The synergistic effects of betanin and radiotherapy in a prostate cancer cell line: an in vitro study;Molecular Biology Reports;2023-10-09
3. 7-Geranyloxcycoumarin enhances radio sensitivity in human prostate cancer cells;Molecular Biology Reports;2023-05-22
4. Drivers of Radioresistance in Prostate Cancer;Journal of Clinical Medicine;2022-09-24
5. 7-Geranyloxcycoumarin enhances radiosensitivity in human prostate cancer cells;2022-08-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3